Back to search
Systemic Lupus Erthematosus
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Systemic Lupus Erthematosus trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Systemic Lupus Erthematosus trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Background: The cause of fatigue is not well understood. It can be felt differently by different people. Some people think there are different types of fatigue…
This is a phase II randomized, placebo-controlled, double-blind, cross-over study to determine the effect of isolevuglandin (IsoLG) scavenging by 2-HOBA on bloo…
This is an exploratory, open-label, single-arm clinical study designed to evaluate the safety, tolerability, and preliminary efficacy of QT-219CX. QT-219CX is a…
The goal of this prospective observational quality improvement study is to determine if a physician tool, MedSafer, combined with educational brochures for pati…
This is an exploratory, open-label, single-arm Phase 1 clinical study designed to evaluate the safety, tolerability, and preliminary efficacy of QT-219C. QT-219…
This Phase 1, open label, dose escalation study evaluates the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary clinical activity of HB2…
This is an investigator-initiated, open-label, single-arm, dose-escalation and dose-expansion study to evaluate the safety, tolerability, PK, PD, and preliminar…
Budoprutug is a humanized, immunoglobulin (Ig) G1 monoclonal antibody that selectively binds to CD19 and is projected to deplete targeted cells through antibody…